Aclaris Therapeutics, Inc.
Clinical trials sponsored by Aclaris Therapeutics, Inc., explained in plain language.
-
New drug tested for painful skin condition
Disease control CompletedThis study tested an experimental drug called ATI-450 against a placebo in 95 people with moderate to severe hidradenitis suppurativa, a painful skin condition. Researchers wanted to see if ATI-450 could reduce the number of painful skin lumps and improve patients' quality of lif…
Phase: PHASE2 • Sponsor: Aclaris Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
New skin treatment shows promise for eczema relief
Disease control CompletedThis study tested an experimental drug called ATI-2138 in 14 adults with moderate to severe atopic dermatitis (eczema) for 12 weeks. Researchers wanted to see if the drug was safe and if it could reduce skin inflammation and itching. The study measured changes in skin severity, i…
Phase: PHASE2 • Sponsor: Aclaris Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:20 UTC